指南与共识乳腺癌放疗

胸壁临床靶区背侧边界国际勾画指南缺乏共识:对危及器官剂量及现代复发模式的影响

The Lack of Consensus of International Contouring Guidelines for the Dorsal Border of the Chest Wall Clinical Target Volume: What is the Impact on Organs at Risk and Relationships to Patterns of Recurrence in the Modern Era?
指南 / 共识 · Adv Radiat Oncol · 2018-09-27

本研究回顾性分析2005至2017年女性胸壁复发模式,并比较5例左乳切除术后放疗患者按RTOG、ESTRO及本中心三种胸壁CTV背侧边界勾画方案的计划剂量。结果显示不同边界对肺V20Gy、心脏平均剂量及LAD平均剂量有显著影响,本中心复发模式支持更靠前的背侧边界。

要点

  • 三种胸壁CTV背侧边界分别为前胸膜表面(RTOG)、胸大肌前表面(ESTRO)和前肋表面(本中心做法)。
  • RTOG对比ESTRO边界:肺V20Gy 33.5% vs 29.4%(P<.01),心脏平均剂量5.2 Gy vs 3.2 Gy(P=.02),LAD平均剂量27.3 Gy vs 17.8 Gy(P=.04)。
  • 本中心复发模式:64.7%皮肤及皮下组织,23.5%胸大肌前及肌间,11.8%仅胸大肌与胸小肌之间,胸小肌深面无复发。

核心结论

  • 胸壁CTV背侧边界的推荐差异对心脏和肺剂量有显著影响。
  • 尽管研究受样本量小限制,本中心复发模式支持更靠前的胸壁CTV背侧边界,与较早文献一致。

研究设计与样本

  • 回顾性评估2005至2017年接受治疗女性的胸壁复发模式,并按推荐CTV边界量化。
  • 比较5例接受左乳切除术后放疗女性的治疗计划,胸壁CTV分别采用三种背侧边界勾画:前胸膜表面(RTOG)、胸大肌前表面(ESTRO)和前肋表面(本中心做法)。
  • 治疗计划为50 Gy分25次,危及器官剂量采用配对样本t检验比较。

主要发现

  • 本中心胸壁复发模式为64.7%皮肤及皮下组织,23.5%胸大肌前及肌间,11.8%仅胸大肌与胸小肌之间。
  • 胸小肌深面未见胸壁复发。
  • RTOG对比ESTRO勾画指南计划:平均肺V20Gy为33.5% vs 29.4%(P<.01)。
  • RTOG对比ESTRO勾画指南计划:心脏平均剂量为5.2 Gy vs 3.2 Gy(P=.02)。
  • RTOG对比ESTRO勾画指南计划:左前降支动脉平均剂量为27.3 Gy vs 17.8 Gy(P=.04)。

关键数值与推荐

  • RTOG推荐的胸壁CTV背侧边界为前胸膜表面。
  • ESTRO推荐的胸壁CTV背侧边界为胸大肌前表面。
  • 本中心做法为胸壁CTV背侧边界取前肋表面。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文自述研究受样本量小限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Variation exists in cooperative group recommendations for the dorsal border for the chest wall clinical target volume (CTV). We aimed to quantify the impact of this variation on doses to critical organs and examine patterns of chest wall recurrence relative to the pectoralis muscle. METHODS AND MATERIALS: We retrospectively assessed patterns of chest wall recurrence quantified to the recommended CTV borders for women treated between 2005 and 2017. We compared treatment plans for 5 women who were treated with left postmastectomy radiation therapy, with the chest wall contoured using varying dorsal borders for CTV: (1) Anterior pleural surface (Radiation Therapy Oncology Group), (2) anterior surface of pectoralis major (European Society for Radiotherapy and Oncology), and (3) anterior rib surface (institutional practice). Treatment plans were generated for 50 Gy in 25 fractions. Doses to organs-at-risk were compared using paired-sample t tests. RESULTS: Institutional patterns of chest wall recurrence were 64.7% skin and subcutaneous tissue, 23.5% both anterior to and between the pectoralis muscles, and 11.8% isolated to the tissue between the pectoralis major and minor. No chest wall recurrences were noted deep to pectoralis minor. When comparing the plans generated per the Radiation Therapy Oncology Group versus European Society for Radiotherapy and Oncology contouring guidelines, the mean lung V20Gy, heart mean dose, and left anterior descending artery mean dose were 33.5% versus 29.4% (P < .01), 5.2 Gy versus 3.2Gy (P = .02), and 27.3Gy versus 17.8Gy (P = .04), respectively. CONCLUSIONS: The recommended variations in the dorsal chest wall CTV border have significant impact on doses to the heart and lungs. Although our study was limited by small numbers, our institutional patterns of recurrence would support a more anterior dorsal border for the chest wall CTV consistent with older literature.

来源:Adv Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Pifer PM, Bice RP, Jacobson GM, et al. The Lack of Consensus of International Contouring Guidelines for the Dorsal Border of the Chest Wall Clinical Target Volume: What is the Impact on Organs at Risk and Relationships to Patterns of Recurrence in the Modern Era? Adv Radiat Oncol. 2018. PMID: 30706008. doi:10.1016/j.adro.2018.09.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。